AUTHOR AND EDITOR INFORMATION

Section 1 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

INTRODUCTION

Section 2 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Background

Nephrocalcinosis was a termed coined by Albright in 1934 to describe the deposition of calcium salts in the renal parenchyma in hyperparathyroidism.¹ The term has now acquired more of a radiologic concept, and it is used to describe diffuse, fine, renal parenchymal calcification that is radiologically demonstrable. This appearance is different from that of calcification within the lumen of the collecting system, ureter, and bladder, which represents nephrolithiasis.

Many causes of nephrocalcinosis have been added since the original description. These include the several causes of hypercalcemia and hypercalciuria. Nephrocalcinosis can be subdivided into the cortical type, which is classically the result of acute tubular necrosis (ATN), and the medullary type, which may be an extension of cortical nephrocalcinosis or is seen in isolation with several metabolic disorders.²

In nephrology, the term nephrocalcinosis is applied only to the medullary type. Nephrocalcinosis can be demonstrated on plain radiographs, sonograms, or computed tomography (CT) scans.^{3, 4, 5, 6, 7, 8, 9} CT scanning is the most accurate and sensitive technique and, therefore, it is the modality of choice.^{9, 10, 11}

For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center, Osteoporosis and Bone Health Center, and Endocrine System Center. Also, see eMedicine's patient education articles  Kidney Stones, Bone Mineral Density Tests, and Vitamin D: Vital Role in Your Health.

Related eMedicine topics:
Bartter Syndrome
Hyperparathyroidism, Primary
Hyperparathyroidism, Secondary
Nephrolithiasis/Urolithiasis

Related Medscape topics:
Specialty Site Radiology
Specialty Site Urology
CME Drug Insight: Choosing a Drug Treatment Strategy for Women With Osteoporosis--An Evidence-Based Clinical Perspective
CME/CE Endocrine Emergencies
CME Hereditary Etiologies of Hypomagnesemia
CME Vitamin D3 for 1 Year Is Safe in Adolescents

Pathophysiology

Disorders of calcium metabolism

Disorders of calcium metabolism, such as hypercalcemia and hypercalciuria, may induce the formation of calcium renal stones and deposition of calcium salts in the renal parenchyma (nephrocalcinosis). The extensive deposition of calcium may lead to chronic tubulointerstitial disease and renal insufficiency. The first signs of damage induced by hypercalcemia are seen at the intracellular level, in the tubular epithelial cells. This results in mitochondrial distortion, and eventually, calcium deposits can be demonstrated within the mitochondria, the cytoplasm, and the basement membrane.

Calcified cellular debris results in occlusion of the tubules, leading to obstructive atrophy of the nephron, nonspecific inflammation, and interstitial fibrosis. Impaired urine drainage through calcified tubules may result in areas of cortical atrophy leading to scarred cortices. A functional abnormality of urine concentration is the earliest detectable renal change. This effect is related to decreased chloride transport in the ascending thick segment of the nephron.

Other defects of tubular function, such as tubular acidosis and salt-losing nephritis, may also occur. The continuing and unchecked deposition of calcium eventually leads to chronic renal insufficiency. Nephrocalcinosis may be complicated by renal stone formation, which adds another element to the causation of renal insufficiency secondary to an obstructive uropathy. The histologic findings include calcium phosphate or calcium oxalate crystal deposits that mainly appear in the renal interstitium, but deposits may also be seen within the renal tubules. Special stains, such as the von Kossa and Pizzolato stains, can be used to specifically depict these deposits.

Causes of cortical nephrocalcinosis

Acute cortical necrosis

Acute cortical necrosis implies death of the renal cortex, with sparing of the renal medulla. This can follow placenta abruptio, placenta previa, septic abortion, transfusion reactions, burns, snake bite, severe dehydration, shock, severe heart failure, and abdominal aortic surgery. In children, the condition may follow dehydration, fever, sepsis, and hemolytic uremic syndrome.

The pathogenesis of acute cortical necrosis is multifactorial and related to a combination of cortical ischemia from vasospasm of small blood vessels, toxic damage to the glomerular capillary endothelium, and primary intravascular thrombosis after an excessive release of thromboplastin. Acute cortical necrosis is usually global, leading to a rapid and permanent renal failure. In focal disease with some sparing of the renal cortex, life can be sustained with dialysis.

Chronic glomerulonephritis

Chronic glomerulonephritis is the second most common cause of cortical nephrocalcinosis after acute cortical necrosis, although radiologic evidence of calcification is rare in both conditions.

Alport syndrome

Alport syndrome involves a hereditary nephropathy that is associated with deafness. This syndrome may cause cortical nephrocalcinosis indistinguishable from that caused by many other etiologies.

Prolonged hypercalcemia and/or hypercalciuria

Prolonged hypercalcemia and/or hypercalciuria may involve conditions such as hyperparathyroidism, vitamin D intoxication, beryllium poisoning, systemic sarcoidosis, milk-alkali syndrome, hyperthyroidism, Addison disease, idiopathic hypercalcemia of infancy, increased bone catabolism associated with myeloma, disseminated metastatic bone disease, leukemia, and immobilization. Most of these result in nephrolithiasis rather than nephrocalcinosis.

Poisoning and toxicity

Ethylene glycol (antifreeze) poisoning can cause marked ballooning and hydropic or vacuolar degeneration of the proximal convoluted tubules. Calcium oxalate crystals are usually found in the tubular lumen in such poisonings. Ethylene glycol can lead to secondary hyperoxaluria. This is actually ATN in which there is destruction of tubular cells

A severe form of primary hyperoxaluria results in the deposition of calcium oxalate crystals in many organs besides the kidneys. The calcific deposits in the convoluted tubules may add a stippled or diffuse increase in the radiopacity to the kidneys. Excessive ingestion of oxalates can give rise to a similar appearance. The metabolic defect is hepatic in origin. Therefore, both renal and liver transplant are required in the treatment of the disease.

Methoxyflurane anesthesia toxicity can cause calcium oxalate deposits in the proximal and distal convoluted tubules. Methoxyflurane anesthesia is a cause of secondary hyperoxaluria.

Other causes

Rejected renal transplants can give rise to cortical necrosis.

Sickle cell disease is a rare cause of cortical nephrocalcinosis. Sickle cell disease is related to infection.

Vitamin B6 (pyridoxine) deficiency can be associated with xanthurenic aciduria that is related to deficiency of the phosphate-dependent enzyme kynureninase. Vitamin B6 (pyridoxine) deficiency is another cause of secondary hyperoxaluria. It is a rare cause of cortical nephrocalcinosis.

Causes of medullary nephrocalcinosis

Hyperparathyroidism

Hyperparathyroidism results in renal lithiasis in 20% of patients, with radiographically detectable nephrocalcinosis in as many as 11% of patients. Both the primary and secondary forms of hyperparathyroidism may affect the kidney, although both lithiasis and nephrocalcinosis are rare in the secondary disease. Nephrocalcinosis in hyperparathyroidism is confined to the lumina of the distal collecting ducts.

Medullary sponge kidney

The pathogenesis of medullary sponge kidney is unknown. Most authors believe this disease is a developmental defect that affects the formation of the collecting tubules. Others suggest it is a progressive degeneration of the collecting tubules that occurs later in life and the primary abnormality is hyperplasia of part of medullary collecting tubules.

Histologic sections show multiple cysts representing dilatated terminal collecting tubules; these measure 1-7 mm. The cysts usually communicate with collecting tubules proximally and with the papillary ducts or calyx distally. Intercommunicating and noncommunicating cysts are occasionally seen. Calculi may be seen within these cysts.

Tuberculosis of the kidneys

Tuberculosis of the kidneys usually spreads via a hematogenous route from pulmonary disease, although it is occasionally secondary to tuberculosis of the gastrointestinal (GI) tract or bone. By the time renal tuberculosis is diagnosed, the primary source of pulmonary infection may be inactive or calcified. The true prevalence of renal tuberculosis is underestimated because radiologic signs may be absent. Moreover, tubercle bacilli are found in 7-29% of urine samples in patients with extrarenal tuberculosis.

The course of renal tuberculosis may be indolent, with the appearance of few, if any, symptoms. The presentation is usually late, and symptoms usually occur as a nonspecific urinary tract infection. Constitutional symptoms usually do not occur or are sparse. Renal tuberculosis is bilateral, although radiologic findings are asymmetric and unilateral in 25% of patients. Ultimately, the kidney becomes atrophic, scarred, densely calcified, and nonfunctioning (autonephrectomy) if the condition is not appropriately treated.

Renal tubular acidosis

Renal tubular acidosis (RTA) includes a group of diseases of diverse etiology. Type I RTA is characterized by abnormalities of hydrogen ion transfer from the blood to the urine in the distal tubules, and type II RTA is characterized by the impairment of bicarbonate conservation by the kidneys. Patients with type I disease are unable to excrete acidic urine and develop profound metabolic conditions, including problems with calcium and phosphate balance. Both nephrocalcinosis and nephrolithiasis eventually develop in 70% of the patients.

The disease may be primary or idiopathic or secondary to a variety of diseases. The primary form (Lightwood syndrome) may be transient and occurs more often in male infants. If these infants survive with treatment, they rarely develop radiologic evidence of nephrocalcinosis. However, a few infants do show spotty renal calcification.

The more common type of primary type I RTA is a chronic disease that is inherited in an autosomal dominant manner (Butler-Albright disease). This type predominantly affects girls aged 2 years or older and adults of both sexes. Nephrolithiasis and nephrocalcinosis affect over 70% of the patients. The secondary form of type I RTA occurs as a result of a variety of causes. These include hypercalcemia; Wilson disease; hyperglobulinemias; and drug toxicity from amphotericin, outdated tetracycline, triamterene, and acetazolamide. Type II RTA does not usually cause calculi.

Renal papillary necrosis

Renal papillary necrosis refers to ischemic necrobiosis of papilla in the medulla of kidney. A number of conditions can cause renal papillary necrosis, all associated with ischemia (hemoglobin S [Hgb S] infection, including that due to tuberculosis, analgesic drugs, cirrhosis). Renal papillary necrosis can be localized or diffuse, and it can be unilateral or bilateral. Early in the disease, renal size and function are preserved, but function may deteriorate with eventual renal failure in the later stages of the disease.

Immobilization

Immobilization may lead to hypercalcemia and hypercalciuria as a result of bone resorption. Immobilized children are particularly prone to calcium metabolic changes because of their active bone growth. Osseous demineralization can occur, and excessive soluble products of calcium and phosphate can precipitate in the renal tubules to form renal calculi. In immobilized patients, the frequency of lithiasis increases with urinary tract infections.

Milk-alkali syndrome

Milk-alkali syndrome is the result of the ingestion of large quantities of calcium. The alkaline urine facilitates the precipitation of calcium-containing calculi. However, this is no longer true in peptic ulcer disease with the use of H2 blockers and the antibiotic treatment of Helicobacter pylori.

Hypervitaminosis D

Excessive vitamin D ingestion (hypervitaminosis D) facilitates increased absorption of calcium from the gut and may cause nephrocalcinosis. A similar complication may occur as a result of treatment of vitamin-resistant rickets in which large doses of vitamin D are used with doses large enough to produce nephrocalcinosis in association with osteomalacia. In this instance, the osseous change is the result of primary disease, and the renal change is the result of treatment. This process is unlike that of type I RTA in which the reverse is true. This is a rare cause of nephrocalcinosis.

Idiopathic hypercalcemia of infancy can produce metabolic changes similar to those of hypervitaminosis D. This condition is related to an inborn error of vitamin D metabolism in which elevated blood levels of vitamin D are present. The affected infants may exhibit dwarfism, elfin facies, mental retardation, and osteosclerosis. Renal failure and hypertension develop secondary to hypercalcemia, hypercalciuria, and nephrocalcinosis.

Sarcoidosis

Sarcoidosis is not infrequently associated with hypercalciuria, which may occur in the absence of hypercalcemia. Both nephrocalcinosis and nephrolithiasis may ensue as a result. Hypercalciuria is due to increased vitamin D absorption from the GI tract, possibly caused by increased sensitivity to vitamin D. When patients present with nephrocalcinosis and nephrolithiasis, pulmonary and mediastinal changes are usually evident. Sarcoid renal granulomas occur but rarely become calcified. This is a rare cause of nephrocalcinosis.

Nephrocalcinosis

Nephrocalcinosis has been described in 16% of preterm infants,¹² although a study examining the long-term effects of neonatal nephrocalcinosis on renal function showed spontaneous resolution in 75% of cases and appeared to indicate that nephrocalcinosis is not associated with renal dysfunction in the long term.¹³ On univariate analysis, gestational age, male sex, duration of ventilation, oxygen dependency, duration and frequency of gentamicin treatment, toxic gentamicin/vancomycin levels, low fluid intake, and postnatal dexamethasone were significantly associated with nephrocalcinosis.¹²

Nephrocalcinosis has been described in premature infants treated with high doses of furosemide for prolonged periods because of congestive heart failure secondary to patent ductus arteriosus or pulmonary disease.^{14, 15} Both nephrocalcinosis and nephrolithiasis may occur. These complications occur 11-50 days after the commencement of furosemide therapy. The addition of chlorothiazide to furosemide prevents further calculi formation, and it may also lead to the dissolution of existing stones. Therefore, preterm infants who are taking furosemide should be regularly screened with renal ultrasonography. Long-term furosemide abuse can also cause medullary nephrocalcinosis in adults.^{16, 17}

Hyperoxaluria

Primary hyperoxaluria is an autosomal recessive disorder involving both excessive production and the urinary excretion of oxalate. Primary hyperoxaluria may cause nephrocalcinosis and nephrolithiasis as a result of deficiency of the enzyme carboligase. Two types are described. In type I, a deficiency of ketoglutarate-glyoxylate carboxylase is observed, and patients present with glycolic aciduria. In type II disease, a deficiency of D-glycerate dehydrogenase occurs, and patients present with 1-glyceric aciduria.

Male and female children are equally affected. They usually present with renal lithiasis and nephrocalcinosis before the age of 5 years. These have a progressive course, and, if untreated, they result in death from renal failure. Associated liver transplantation is required to correct the metabolic defect.

Secondary hyperoxaluria is a much rarer condition, and it is associated with disturbance of bile acid metabolism. The causes of secondary hyperoxaluria include a short small bowel as a result of ileal resection or jejunoileal bypass, Crohn disease, blind loop syndrome, and increased ingestion of green, leafy vegetables. This usually occurs as nephrolithiasis rather than nephrocalcinosis.

Glucose-galactose malabsorption

Soylu et al described an association between hypercalcemia, nephrocalcinosis, and proximal tubular dysfunction, which may be seen in association with glucose-galactose malabsorption, in a 50-day-old girl with glucose-galactose malabsorption who was found to have nephrocalcinosis but no sign of nephrolithiasis.¹⁸ The authors noted that most of these abnormalities improved with a glucose-galactose-free diet. The infant was found to have a novel mutation of Na(+)-dependent glucose transporter (SGLT1).

Miscellaneous causes

A variety of conditions can cause bone destruction that is associated with hypercalcemia and hypercalciuria. These include bony metastases, multiple myeloma, Paget disease, Cushing disease, and both hyperthyroidism and hypothyroidism (although the incidence associated with hypothyroidism is low). Chronic paraneoplastic hypercalcemia may also cause nephrocalcinosis.

Sickle cell anemia is a rare cause of nephrocalcinosis. A variety of radiographic renal abnormalities have been associated with sickle cell disease, including renal enlargement, thickening of the renal cortex, focal hypertrophy, papillary necrosis, and changes associated with infection.

Ochronosis (alkaptonuria) is an autosomal recessive disorder involving deficiency of the enzyme homogentisic acid oxidase. It is a rare cause of nephrocalcinosis; renal stone formation is more common.

Frequency

United States

Regarding cases of nephrocalcinosis and nephrolithiasis in children, 64% are associated with an underlying structural renal lesion or urinary tract infection, 10% are associated with hypercalcemia or hypercalciuria, 6% are associated with cystinuria, and 20% are idiopathic (as many as 50% in some series). Oxalosis and miscellaneous conditions may be involved.

In adults, 40% of cases of medullary nephrocalcinosis are attributed to hyperparathyroidism, and 20% are attributed to RTA. The remaining 40% are divided among the other multiple causes. Conversely, 5% of patients with hyperparathyroidism have nephrocalcinosis. The medullary type accounts for 95% of all nephrocalcinosis, whereas 5% represent cortical nephrocalcinosis. In 70% of patients with RTA type I, both nephrocalcinosis and nephrolithiasis eventually develop.

International

No reliable data are available regarding the frequency and prevalence of nephrocalcinosis.

Mortality/Morbidity

Mortality and morbidity depend on the cause of nephrocalcinosis.

• An association with malignant bone disease obviously has a poor prognosis. Unchecked nephrocalcinosis eventually leads to renal dysfunction. Again, the degree of renal impairment depends on the etiology of the nephrocalcinosis. Acute cortical necrosis may lead to a rapid and permanent renal failure. However, in focal disease with some sparing of the renal cortex, life can be sustained, although renal function is impaired.
• Children of both sexes with primary oxaluria usually present with progressive disease, which, if untreated, results in death from renal failure in childhood.
• Some conditions causing nephrocalcinosis are associated with profound metabolic disturbances that have their own associated complications. Growth retardation in children is commonly seen in patients with underlying metabolic disease. Treatment, whether medical or surgical, has its own morbidity and mortality.

Race

No racial or ethnic predilection is observed.

Sex

Males and females are equally affected.

Age

All age groups can be affected, but the disease is more common in childhood than at other times.

Anatomy

The basic unit of renal function is the nephron (see Image 1), which consists of the glomerulus; the proximal convoluted tubule; the loop of Henle; and the distal convoluted tubule, which finally drains into the collecting ducts. Anatomically, the glomerulus and proximal convoluted tubules are placed in the renal cortex, whereas the descending loop of Henle enters the medullary tissue. The ascending loop goes back to the cortex, where it drains into the distal convoluted tubule. Finally, the distal convoluted tubule drains into the collecting ducts, which again enter the renal medulla and drain into the calyx.

Each normal kidney contains about 1,250,000 nephrons. The gross anatomic renal functioning unit is the lobule, consisting of the medullary pyramid with its base oriented toward the renal cortex and the apex oriented toward the calyx. Its sides are covered by renal cortical columns. At the glomerulus, all the constituents of plasma are filtered, except the cellular elements and the plasma proteins, and are transported via the tubules to the renal sinus. In healthy adults, 180 L of filtrate is formed per day. About 80% of the filtrate is reabsorbed in the proximal convoluted tubule, and 20% is absorbed in the distal tubular structures, dependent on antidiuretic hormone (ADH).

Disorders of calcium metabolism, such as hypercalcemia and hypercalciuria, may cause extensive deposition of calcium within the renal tubules, and chronic tubulointerstitial disease and renal insufficiency may result. Calcified cellular debris results in occlusion of the tubules, leading to obstructive atrophy of the nephron, nonspecific inflammation, and interstitial fibrosis. Impaired urine drainage through calcified tubules may result in areas of cortical atrophy, leading to scarred cortices. Functional abnormality of urine concentration is the earliest detectable renal change (osmolality). This is related to decreased chloride transport in the ascending thick segment of the nephron. Other defects of tubular function, such as tubular acidosis and salt-losing nephritis, may also occur.

Clinical Details

The clinical presentation of nephrocalcinosis is determined by the underlying etiology. Most cases are asymptomatic, and nephrocalcinosis is identified as a radiologic abnormality. Renal tubular disorders may be first diagnosed on biochemical examination of the urine, which often reveals glycosuria, aminoaciduria, and phosphaturia. Polyuria and polydipsia may be the presenting features, with loss of the concentrating ability of the renal tubules.

With the advent of multichannel analyzers, most cases of hyperparathyroidism are now recognized with routine blood testing. Approximately 50% of the patients with hypercalcemia are hypertensive because of increased vasoconstriction as a result of calcium deposition within the arterioles and because of an increased release of catecholamines. Occasionally, symptoms from recurrent urinary tract infections may be the presenting features. Recurrent abdominal pain and hematuria may be present in children and adults. Associated nephrolithiasis may present acutely with colic.

Related Medscape topics:
Resource Center Thyroid Disease
Specialty Site Gastroenterology
Specialty Site Nephrology
Specialty Site Pathology & Lab Medicine
Specialty Site Radiology
Specialty Site Urology

Preferred Examination

Most cases of nephrocalcinosis are asymptomatic and usually identified on plain abdominal radiographs. Planar radiography provides a useful adjunct to plain radiography. Nonenhanced CT scans can also depict nephrocalcinosis, and its apparent sensitivity and accuracy make CT scanning the modality of choice.

Ultrasonography is noninvasive, ideal for use in young children, quick to perform, and accurate. Early in its course, medullary nephrocalcinosis can be seen as echogenic pyramids before nephrocalcinosis can be identified on plain abdominal radiographs.

Limitations of Techniques

Usually, nephrocalcinosis cannot be detected on plain radiographs until the attenuation exceeds 100 Hounsfield units (HU). Optimal imaging must be used to produce the right factors for radiographic accuracy. The radiation burden with CT scanning is a disadvantage in the young. Ultrasonography remains operator dependent, and its accuracy is affected by the patient's body habitus.

DIFFERENTIALS

Section 3 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Other Problems to be Considered

Bartter syndrome
Cystinuria
Hyperoxaluria
Hyperuricuria
Hypomagnesemia-hypercalciuria syndrome
Idiopathic hypercalciuria
RTA (distal)

RADIOGRAPH

Section 4 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Findings

Plain radiographic detection is not possible until the attenuation of renal parenchyma exceeds 100 HU. The calcification resolution also depends on the size of the stones (those <2 mm are rarely detected), the spatial resolution of the recoding technique, and contrast factors. The characteristic cortical calcification occurs within a few weeks after the onset of acute cortical necrosis. When cortical nephrocalcinosis first appears, the kidneys are still enlarged because of inflammatory edema of the kidneys. With time, the kidneys atrophy.

Morphologically, 3 types of calcification have been described. The most prevalent is a single cortical, calcified, and thin peripheral band, often with calcified extensions into the necrotic septa of Bertin (placed perpendicular to the cortical calcification). The medullary pyramids are usually spared, retaining the attenuation of the soft tissue. Initially, this pattern of nephrocalcinosis may be difficult to recognize because the calcification is faint. However, the kidney margins appear both well defined and penciled in.

The second pattern seen with cortical nephrocalcinosis is the appearance of hyperattenuating tram lines. These lines may be continuous, but more often, they are interrupted, reflecting the more patchy distribution of cortical necrosis.

The third pattern is a more diffuse distribution of punctate calcification. This punctate pattern of calcification is thought to represent necrotic calcified glomeruli and tubules.

Medullary nephrocalcinosis typically produces clusters of stippled calcifications, mainly within the regions of the renal pyramids.

Most conditions that cause medullary nephrocalcinosis can also result in nephrolithiasis. Some nephroliths may represent extruded deposits from the renal parenchyma. The radiologic demonstration of both nephrocalcinosis and nephrolithiasis also helps in determining their etiology and thus significantly contributes to the management of the disease. Planar conventional tomography provides a cheaper alternative to CT scanning, and it may be a useful adjunct to conventional radiography.

Degree of Confidence

Plain radiography is a noninvasive and fairly sensitive technique for the detection of nephrocalcinosis. The pattern and distribution of the nephrocalcinosis may suggest the underlying cause. Radiographs appear to show more details than CT scans. Radiographs also seem to be more suitable for follow-up of the course of the disease, and they have a lower radiation burden.

False Positives/Negatives

Plain radiographic detection is not possible until an attenuation of 100 HU. Plain radiography cannot be used to differentiate between the various causes of nephrocalcinosis.³

CT SCAN

Section 5 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Findings

CT scanning is said to be the most sensitive imaging modality in the diagnosis of nephrocalcinosis. CT scans depict nephrocalcinosis at an early stage of the disease, provide a better picture of the density and extent of the nephrocalcinosis, and may depict other changes such as renal cysts. In a small series of 13 patients, intravenous urograms showed medullary sponge kidneys (24 kidneys), whereas nonenhanced CT scans showed papillary calcifications in 11 kidneys, 5 of which were not detectable on plain radiographs.¹⁹ Hyperattenuating papillae (55-70 HU) without calcification were found in 4 other kidneys.

Hyperoxaluria is characterized by nephrocalcinosis on radiologic examination, and this condition is associated with nephrolithiasis and calcium oxalate crystal deposition in multiple extrarenal organs. CT scanning is a sensitive modality for the detection of systemic oxalosis (eg, in the liver and heart), in addition to nephrocalcinosis. Bilateral attenuating rings in the renal medulla were depicted on nonenhanced CT scans in a patient with marked hypercalcemia and suspected hyperparathyroidism.²⁰

Degree of Confidence

Nonenhanced CT scans can depict nephrocalcinosis, and because CT scanning appears to be the most sensitive and accurate technique, it is the modality of choice. CT scanning is more sensitive than plain radiography in the detection of papillary calcifications, the most frequent complication of medullary sponge kidney.

False Positives/Negatives

The sensitivity of contrast-enhanced CT scanning in the detection of medullary sponge kidneys is markedly lower than that of excretory urography.¹⁹ CT images only suggest the possibility of medullary sponge kidneys. This will change with multidetector-row CT (MDCT) scanners and dedicated reformatting protocols.

MRI

Section 6 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Findings

Magnetic resonance imaging (MRI) is rarely required to diagnose nephrocalcinosis because it does not depict calcium as such.

ULTRASOUND

Section 7 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Findings

In medullary calcinosis, the margins of the pyramids are echogenic, whereas the center of pyramids remains echolucent. The pyramids are well visualized as rounded or echogenic structures. The pyramids may be densely echogenic, and shadowing may be shown. These findings may be evident on sonograms before they are seen on plain radiographs.

Renal cortical calcification causes increased cortical echogenicity with complete shadowing in severe cases. Secondary pyramidal fibrosis may occur; these may cause echogenic pyramids.

Degree of Confidence

Early medullary nephrocalcinosis can be seen as echogenic pyramids before nephrocalcinosis can be identified on plain abdominal radiographs.

False Positives/Negatives

Causes of focal increases in renal echogenicity (usually nonshadowing) include the following: chronic infarction (eg, Hgb S), acute bacterial focal nephritis, angiomyolipoma, hemangioma, oncocytoma, and malignancy (eg, renal cell carcinoma, sarcoma, metastases).

The differential diagnosis of echogenic renal pyramids in children includes nephrocalcinosis as the single most frequent cause. However, a multitude of other causes involve echogenic pyramids in the absence of nephrocalcinosis. These include the following:

• Protein deposits – Proteinuria (dehydration), toxic shock syndromes, sepsis, degenerative leukoencephalopathy, and hypotensive and/or hypovolemic shock
• Vascular congestion and/or occlusion – Sickle cell disease
• Systemic infection – Bacterial septicemia, candidal infection, cytomegaloviral infection, acquired immunodeficiency syndrome (AIDS)²¹ (eg, Mycobacterium avium-intracellulare, Pneumocystis carinii)
• Metabolic – Gout, Lesch-Nyhan syndrome, glycogen storage disease, hypokalemia, primary aldosteronism, pseudo-Bartter syndrome, Wilson syndrome, Fanconi syndrome, tyrosinosis, cholestatic jaundice, oxalosis, alpha-antitrypsin deficiency
• Fibrosis – Renal pyramidal fibrosis, congenital hepatic fibrosis
• Unknown causes – Pyloric stenosis, metabolic alkalosis, tubular ectasia, intrarenal reflux, Crohn disease
• Cystic medullary disease – Medullary sponge kidney

Echogenic pyramids and hyperechoic rings may be present in the periphery of the renal pyramids in adults. These can be divided into 2 groups: normal variants and nephrocalcinosis. Nephrocalcinosis can be subdivided as follows:

• Hypercalcemia
• Hypercalciuria
• Medullary sponge kidney
• Oxalosis
• No nephrocalcinosis
• • Renal tubular ectasia
  • Medullary sponge kidney
  • Congenital hepatic fibrosis
  • Sarcoidosis
  • Hyperuricemia
  • Glomerulonephritis
  • Rheumatoid arthritis with amyloid
  • Analgesic nephropathy
  • Hypocalcemia
  • Hypokalemia
  • Addison disease (normal calcium, potassium, and uric acid levels)
  • AIDS-related M avium-intracellulare infection, in which the increased attenuation is secondary to protein contents

Related Medscape topics:
Specialty Site Gastroenterology
Specialty Site Hematology-Oncology
Specialty Site Nephrology
Specialty Site Pulmonary Medicine
Specialty Site Radiology
Specialty Site Rheumatology

NUCLEAR MEDICINE

Section 8 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Findings

The role of nuclear medicine is confined to assessing renal function by means of isotope renography, particularly when renal surgery is being considered.

INTERVENTION

Section 9 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Extracorporeal shock wave lithotripsy (ESWL) may be indicated in cases of intrapelvic renal stones (nephrocalcinosis). Parathyroidectomy may be required to control hypercalcemia that is caused by hyperparathyroidism. This technique is good for stones smaller than 5 mm, satisfactory for stones 5-10 mm, and rarely used for stones larger than 10 mm because of the possibility of the debris load causing steinstrasse.

Medical/Legal Pitfalls

• Nephrocalcinosis found incidentally may be the presenting feature of a variety of inborn errors of metabolism, and the radiologist may be the first to suggest a diagnosis based on the pattern and distribution of renal parenchymal disease. Therefore, the radiologist must be aware of the causes of nephrocalcinosis.
• A misdiagnosis of nephrocalcinosis may lead to irreversible renal failure that causes unnecessary suffering for the patient. Early recognition is important because changes are usually reversible. Differentiating between nephrolithiasis and nephrocalcinosis is also important because the 2 conditions are managed differently, although in some conditions, the 2 may coexist.^{10, 22}

Related Medscape topics:
Resource Center Medical Malpractice and Legal Issues
Specialty Site Diabetes & Endocrinology
Specialty Site Nephrology
Specialty Site Radiology

Special Concerns

• Nephrocalcinosis is rare in pediatric patients, but it may occur in neonates and premature babies.^{23, 24, 25, 26, 27, 28} Recognition is therefore important to prevent renal failure and long-term effects.
• Nephrocalcinosis may be the first manifestation of many familial metabolic disorders, or it may appear as a complication of drug therapy, particularly treatment with diuretics. Prompt recognition is therefore important to modulate treatment.

Related Medscape topics:
Resource Center Adverse Drug Events Reporting
Resource Center Neonatal Medicine
Specialty Site Pediatrics

MULTIMEDIA

Section 10 of 11  

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

Media file 1:  Diagram of a nephron.
	View Full Size Image
Media type:  Illustration

Media file 2:  Radiograph depicting bilateral nephrocalcinosis in an adult male patient who initially presented with features of pancreatitis. Ultimately, hyperparathyroidism was diagnosed. Note the mesenteric nodal calcification just below the level of left kidney.
	View Full Size Image
Media type:  X-RAY

Media file 3:  Radiograph depicting kidneys with bilateral pyramidal calcification, which is consistent with nephrocalcinosis, most likely hyperparathyroidism (same patient in Images 3-4).
	View Full Size Image
Media type:  X-RAY

Media file 4:  Radiograph of both hands in a patient who also has bilateral pyramidal calcification (same patient in Images 3-4). This image shows bilateral subperiosteal resorption along the radial aspect of middle phalanx. This finding is consistent with hyperparathyroidism.
	View Full Size Image
Media type:  X-RAY

Media file 5:  Sonogram of the right kidney in a woman with nephrocalcinosis. This image shows hyperechoic foci in the pyramids.
	View Full Size Image
Media type:  Ultrasound

Media file 6:  Excretory urogram obtained at 15 minutes in a man with renal papillary necrosis, most likely a patient with diabetes mellitus and repeated urinary tract infections (same patient in Images 6-7). This image shows bilateral hydronephrosis and a hydroureter due to obstruction by sloughed papillae at the lower end of the ureter.
	View Full Size Image
Media type:  X-RAY

Media file 7:  Plain kidney, ureters, and bladder (KUB) radiograph in a man with renal papillary necrosis, most likely a patient with diabetes mellitus and repeated urinary tract infections (same patient in Images 6-7). This image shows bilateral renal calcification. A large, sloughed, and calcified renal papilla is present in the region of left vesicoureteric junction. Note the 2 pelvic phleboliths opposite the ischial spine on the right.
	View Full Size Image
Media type:  X-RAY

Media file 8:  Plain abdominal radiograph in a 40-year-old man (same patient in Images 8-9). This image shows extensive calculus formation in a medullary sponge kidney.
	View Full Size Image
Media type:  X-RAY

Media file 9:  Radiograph from an intravenous urographic series in a 40-year-old man (same patient in Images 8-9). The image was obtained after contrast injection and shows contrast-agent accumulation in the collecting tubules in a medullary sponge kidney.
	View Full Size Image
Media type:  X-RAY

Media file 10:  Sonogram of a kidney in a patient with medullary sponge kidney. This image shows a hyperechoic medulla associated with echogenic foci, some of which are casting shadows. A hyperechoic medulla can also be seen in conditions that cause hyperuricemia and hypokalemia.
	View Full Size Image
Media type:  Ultrasound

Media file 11:  Top: Plain radiograph of the kidneys in a patient with a long history of renal tubular acidosis (same patient as in bottom image and Image 12). This image shows bilateral pyramidal calcification that is consistent with nephrocalcinosis. Bottom: Sonograms of the kidneys in the same patient as above show a hyperechoic medulla associated with echogenic foci, some of which are casting shadows.
	View Full Size Image
Media type:  Image

Media file 12:  Axial computed tomography scans obtained from a patient with a long history of renal tubular acidosis (same patient as in Image 11). These images show bilateral medullary nephrocalcinosis (early arterial phase).
	View Full Size Image
Media type:  CT

Media file 13:  Nonenhanced coronal computed tomography scans through the kidneys. These images show both cortical and medullary nephrocalcinosis (left kidney). Both kidneys appear scarred. Note the thinning of the renal cortex at the upper pole of the left kidney. This patient gave a long history of chronic pyelonephritis, which is an unusual cause of nephrocalcinosis.
	View Full Size Image
Media type:  CT

REFERENCES

Section 11 of 11

• Authors and Editors
• Introduction
• Differentials
• Radiograph
• CT Scan
• MRI
• Ultrasound
• Nuclear Medicine
• Intervention
• Multimedia
• References

1. Albright F, Baird PC, Cope O, Bloomberg E. Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci. 1934;187(1):49-65.
2. Balogun RA, Adams ND, Palmisano J, et al. Focal segmental glomerulosclerosis, proteinuria and nephrocalcinosis associated with renal tubular acidosis. Nephrol Dial Transplant. Feb 2002;17(2):308-10. [Medline]. [Full Text].
3. Cheidde L, Ajzen SA, Tamer Langen CH, Christophalo D, Heilberg IP. A critical appraisal of the radiological evaluation of nephrocalcinosis. Nephron Clin Pract. 2007;106(3):c119-24. [Medline].
4. Akhan O, Ozmen MN, Coskun M, et al. Systemic oxalosis: pathognomonic renal and specific extrarenal findings on US and CT. Pediatr Radiol. 1995;25(1):15-6. [Medline].
5. Hill SC, Hoeg JM, Avila NA. Nephrocalcinosis in homozygous familial hypercholesterolemia: ultrasound and CT findings. J Comput Assist Tomogr. Jan-Feb 1991;15(1):101-3. [Medline].
6. Falkoff GE, Rigsby CM, Rosenfield AT. Partial, combined cortical and medullary nephrocalcinosis: US and CT patterns in AIDS-associated MAI infection. Radiology. Feb 1987;162(2):343-4. [Medline]. [Full Text].
7. Afschrift M, Nachtegaele P, Van Rattinghe R, et al. Nephrocalcinosis demonstrated by ultrasound and CT. Pediatr Radiol. 1983;13(1):42-3. [Medline].
8. Sumner TE, Volberg FM, Karstaedt N, Ward CF, Lorentz WB. Hypophosphatasia and nephrocalcinosis demonstrated by ultrasound and CT. Clin Nephrol. Dec 1984;22(6):317-9. [Medline].
9. Manz F, Jaschke W, van Kaick G, Waldherr R, Willich E. Nephrocalcinosis in radiographs, computed tomography, sonography and histology. Pediatr Radiol. 1980;9(1):19-26. [Medline].
10. Fuster D. [Pathophysiology and diagnosis of nephrocalcinosis] [German]. Ther Umsch. May 2007;64(5):287-90. [Medline].
11. Igarashi T, Hayakawa H, Shiraga H, et al. Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is the disease identical to Dent's disease in United Kingdom?. Nephron. 1995;69(3):242-7. [Medline].
12. Narendra A, White MP, Rolton HA, et al. Nephrocalcinosis in preterm babies. Arch Dis Child Fetal Neonatal Ed. Nov 2001;85(3):F207-13. [Medline]. [Full Text].
13. Porter E, McKie A, Beattie TJ, et al. Neonatal nephrocalcinosis: long term follow up. Arch Dis Child Fetal Neonatal Ed. Sep 2006;91(5):F333-6. [Medline].
14. Saarela T, Lanning P, Koivisto M, Paavilainen T. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr. Aug 1999;158(8):668-72. [Medline].
15. Solivetti FM, Paganelli C, Zoffoli M, et al. Nephrocalcinosis induced by long-term therapy with furosemide. J Clin Ultrasound. Nov-Dec 1997;25(9):519-20. [Medline].
16. Kim YG, Kim B, Kim MK, et al. Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant. Dec 2001;16(12):2303-9. [Medline]. [Full Text].
17. Simões A, Domingos F, Prata MM. Nephrocalcinosis induced by furosemide in an adult patient with incomplete renal tubular acidosis. Nephrol Dial Transplant. May 2001;16(5):1073-4. [Medline]. [Full Text].
18. Soylu OB, Ecevit C, Altinöz S, et al. Nephrocalcinosis in glucose-galactose malabsorption: nephrocalcinosis and proximal tubular dysfunction in a young infant with a novel mutation of SGLT1. Eur J Pediatr. Feb 21 2008;epub ahead of print. [Medline].
19. Ginalski JM, Schnyder P, Portmann L, Jaeger P. Medullary sponge kidney on axial computed tomography: comparison with excretory urography. Eur J Radiol. Mar-Apr 1991;12(2):104-7. [Medline].
20. Curry NS, Gordon L, Gobien RP, Lott M. Renal medullary "rings": possible CT manifestation of hypercalcemia. Urol Radiol. 1984;6(1):48-50. [Medline].
21. Bargman JM, Wagner C, Cameron R. Renal cortical nephrocalcinosis: a manifestation of extrapulmonary Pneumocystis carinii infection in the acquired immunodeficiency syndrome. Am J Kidney Dis. Jun 1991;17(6):712-5. [Medline].
22. Marengo SR, Romani AM. Oxalate in renal stone disease: the terminal metabolite that just won't go away. Nat Clin Pract Nephrol. Jul 2008;4(7):368-77. [Medline]. [Full Text].
23. Moudgil A, Rodich G, Jordan SC, Kamil ES. Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome. Pediatr Nephrol. Nov 2000;15(1-2):60-2. [Medline].
24. Schell-Feith EA, Kist-van Holthe JE, Conneman N, et al. Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters. Kidney Int. Nov 2000;58(5):2102-10. [Medline]. [Full Text].
25. Rönnefarth G, Misselwitz J. Nephrocalcinosis in children: a retrospective survey. Members of the Arbeitsgemeinschaft für pädiatrische Nephrologie. Pediatr Nephrol. Sep 2000;14(10-11):1016-21. [Medline].
26. Garel L, Filiatrault D, Robitaille P. Nephrocalcinosis in Bartter's syndrome. Pediatr Nephrol. Jul 1988;2(3):315-7. [Medline].
27. Rausch HP, Hanefeld F, Kaufmann HJ. Medullary nephrocalcinosis and pancreatic calcifications demonstrated by ultrasound and CT in infants after treatment with ACTH. Radiology. Oct 1984;153(1):105-7. [Medline]. [Full Text].
28. Cumming WA, Ohlsson A. Nephrocalcinosis in Bartter's syndrome. Demonstration by ultrasonography. Pediatr Radiol. 1984;14(2):125-6. [Medline].
29. al-Murrani B, Cosgrove DO, Svensson WE, Blaszczyk M. Echogenic rings--an ultrasound sign of early nephrocalcinosis. Clin Radiol. Jul 1991;44(1):49-51. [Medline].
30. Brennan RP, Pearlstein AE, Miller SA. Computed tomography of the kidneys in a patient with methoxyflurane abuse. J Comput Assist Tomogr. Jan-Feb 1988;12(1):155-6. [Medline].
31. Campfield T, Bednarek FJ, Pappagallo M, et al. Nephrocalcinosis in premature infants: variability in ultrasound detection. J Perinatol. Oct-Nov 1999;19(7):498-500. [Medline].
32. Cockell KA, L'Abbé MR, Belonje B. The concentrations and ratio of dietary calcium and phosphorus influence development of nephrocalcinosis in female rats. J Nutr. Feb 2002;132(2):252-6. [Medline]. [Full Text].
33. Faqeih E, Al-Akash SI, Sakati N, Teebi PA. Four siblings with distal renal tubular acidosis and nephrocalcinosis, neurobehavioral impairment, short stature, and distinctive facial appearance: a possible new autosomal recessive syndrome. Am J Med Genet A. Sep 1 2007;143A(17):1951-7. [Medline].
34. Forget S, Patriquin HB, Dubois J, et al. The kidney in children with tyrosinemia: sonographic, CT and biochemical findings. Pediatr Radiol. Feb 1999;29(2):104-8. [Medline].
35. Hoffbrand BI, Oppenheimer SM, Sachs ML, Wrong OM. Nodular cortical nephrocalcinosis: a benign and hitherto undescribed form of renal calcification. Nephron. 1987;46(4):370-2. [Medline].
36. Hughes JJ, Wilder WM. Computed tomography of renal sarcoidosis. J Comput Assist Tomogr. Nov-Dec 1988;12(6):1057-8. [Medline].
37. Karstrup S, Hegedüs L, Holm HH. Ultrasonically guided chemical parathyroidectomy in patients with primary hyperparathyroidism: a follow-up study. Clin Endocrinol (Oxf). May 1993;38(5):523-30. [Medline].
38. Lucaya J, Enriquez G, Nieto J, et al. Renal calcifications in patients with autosomal recessive polycystic kidney disease: prevalence and cause. AJR Am J Roentgenol. Feb 1993;160(2):359-62. [Medline]. [Full Text].
39. Miller DL, Doppman JL, Chang R, et al. Angiographic ablation of parathyroid adenomas: lessons from a 10-year experience. Radiology. Dec 1987;165(3):601-7. [Medline]. [Full Text].
40. Mrowka C, Adam G, Sieberth HG, Matern S. Caroli's syndrome associated with medullary sponge kidney and nephrocalcinosis. Nephrol Dial Transplant. Jun 1996;11(6):1142-5. [Medline]. [Full Text].
41. Schell-Feith EA, Holscher HC, Zonderland HM, et al. Ultrasonographic features of nephrocalcinosis in preterm neonates. Br J Radiol. Nov 2000;73(875):1185-91. [Medline]. [Full Text].
42. Schepens D, Verswijvel G, Kuypers D, Vanrenterghem Y. Images in nephrology. Renal cortical nephrocalcinosis. Nephrol Dial Transplant. Jul 2000;15(7):1080-2. [Medline]. [Full Text].
43. Shaer AJ. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Am J Med Sci. Dec 2001;322(6):316-32. [Medline].
44. Shuman WP, Mack LA, Rogers JV. Diffuse nephrocalcinosis: hyperechoic sonographic appearance. AJR Am J Roentgenol. Apr 1981;136(4):830-2. [Medline]. [Full Text].
45. Solbiati L, Giangrande A, De Pra L, et al. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology. Jun 1985;155(3):607-10. [Medline]. [Full Text].
46. Ter Meulen CG, Pieters GF, Huysmans FT. Flaccid paresis due to distal renal tubular acidosis preceding systemic lupus erythematosus. Neth J Med. Mar 2002;60(1):29-32. [Medline]. [Full Text].
47. Toyoda K, Miyamoto Y, Ida M, Tada S, Utsunomiya M. Hyperechoic medulla of the kidneys. Radiology. Nov 1989;173(2):431-4. [Medline]. [Full Text].
48. Verge CF, Lam A, Simpson JM, et al. Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. Dec 26 1991;325(26):1843-8. [Medline].
49. Yeung SJ, McCutcheon IE, Schultz P, Gagel RF. Use of long-term intravenous phosphate infusion in the palliative treatment of tumor-induced osteomalacia. J Clin Endocrinol Metab. Feb 2000;85(2):549-55. [Medline]. [Full Text].

Article Last Updated: Jul 10, 2008